The New Jersey Cannabis Regulatory Commission (NJ-CRC) voted to approve new cannabis testing guidelines during the Commission’s February 18 public meeting. Since June 2021, the Commission has been following Maryland's testing standards.
New Jersey’s cannabis market surpassed $1 billion in combined medicinal and recreational cannabis sales in 2024, marking a nearly 25% increase from the previous year’s total of $800,279,300 and underscoring the robust growth of the Garden State’s regulated cannabis industry.
During its final public meeting of 2024, the New Jersey Cannabis Regulatory Commission (NJ-CRC) voted to begin accepting applications for cannabis consumption area endorsements on January 2, 2025. The commissioners also set the Social Equity Excise Fee (SEEF) at $2.50 per ounce of cannabis.
Further update regarding recently enacted New Jersey statute regulating intoxicating hemp products, P.L. 2024, ch. 73
During a Special Meeting of the New Jersey Cannabis Regulatory Commission on Wednesday, October 30, the agency’s board voted to waive the November 1 regulatory requirement under N.J.A.C. 17:30-3.4(d) to set the 2025 Social Equity Excise Fee (SEEF) amount on the cultivation of recreational cannabis. This extension will allow the NJ-CRC board additional time to determine an appropriate SEEF rate for 2025.
Update regarding recently enacted New Jersey statute regulating intoxicating hemp products, P.L. 2024, ch. 73
The New Jersey Cannabis Regulatory Commission (NJ-CRC) will host a series of virtual roundtables with the hope of hearing from patients, healthcare providers, and cannabis business operators about the health and future of New Jersey’s medicinal cannabis market. The four sessions, organized by the Commission's Public Engagement and Education Committee (PEEC), Product Safety, Packaging, and Labeling Committee (PSPLC), and Permitting and Licensing Committee (P&LC), will be held on September 5, 23, and 25, and October 1, from 11 a.m. to 12:30 p.m.
Green Medicine NJ/"Green Joy", flower and pre-rolls recalled
The New Jersey Cannabis Regulatory Commission (NJ-CRC) has launched a new page on its website dedicated to providing information for and related to municipal governments and their cannabis regulations. The new webpage features a searchable chart of municipalities that opted into the adult cannabis market, filters municipalities by county, and breaks down the types of business classes each municipality is permitting in their jurisdictions.
The New Jersey Cannabis Regulatory Commission's (NJ-CRC) Permitting and Licensing Committee will host a virtual listening session to gather input from license applicants and business operators about their experiences with the cannabis business license application process. The listening session be held via Zoom on Thursday, May 16, 2024, from noon to 2 p.m., and hosted by the committee chair, Maria Del Cid-Kosso, and NJ- CRC’s board chairwoman, Dianna Houenou.
Governor Phil Murphy today announced senior-level personnel transitions within the New Jersey Department of Health (DOH) and the Cannabis Regulatory Commission (CRC). Effective May 20, 2024, Jeff Brown, who currently serves as the Executive Director of CRC, will transition to DOH to serve as the Deputy Commissioner for Health Systems. He will succeed DOH Deputy Commissioner Robin Ford, who is departing on May 10, 2024 for a new role at the New Jersey Innovation Institute. Brown joins former CRC Deputy Executive Director Kelly Anderson-Thomas, who transitioned to DOH as a Deputy Commissioner for Public Health Services earlier this spring.
New Jersey’s recreational cannabis market sales for the first quarter of 2024 totaled more than $201 million — a 38% increase compared to the same period last year. Sales from January to March 2023 were generated by 24 licensed dispensaries, whereas that number increased by 96, to a total of 130 licensed dispensaries, in the same time period in 2024.
The New Jersey Cannabis Regulatory Commission (NJ-CRC) will host a series of registration clinics to assist existing and potential patients and caregivers sign-up or renew enrollment in the Medicinal Cannabis Program (MCP). The registration clinics are designed to give hands-on guidance to patients and caregivers through the program's requirements and procedures, and to answer questions in-person to anyone curious about the program.
The New Jersey Cannabis Regulatory Commission (NJ-CRC) will host a series of virtual meetings to gather community input on the allocation of funds raised from the Social Equity Excise Fee (SEEF) on recreational cannabis sales. Input collected from public comment at the meetings and from written submissions will inform the Commission’s recommendations to the governor and legislature.
New Jersey’s cannabis market earned $800,279,300 in medicinal and recreational cannabis sales in 2023. Added to 2022 sales figures - $555,654,794 – and year-to-date sales in 2024, the burgeoning market has now earned more than $1.3 billion since the beginning of recreational cannabis sales in April 2022. It has eclipsed $2 billion in total sales since the beginning of 2018.
Starting this Friday, March 1, new patients, renewing patients and caregivers in New Jersey Cannabis Regulatory Commission’s (NJ-CRC) Medicinal Cannabis Program will be able to request free digital Medicinal Cannabis Patient (MCP) cards. Patients and caregivers will have the free alternative to paying $10 for physical identification cards.
Just three years shy of the New Jersey Cannabis Regulatory Commission’s (NJ-CRC) establishment and just under two years into adult-use (recreational) sales, the agency’s dispensary directory now lists 102 medicinal and recreational cannabis dispensaries across the state.
The New Jersey Cannabis Regulatory Commission (NJ-CRC) approved rules for cannabis consumption areas in its public meeting on Wednesday, January 17. The new rules establish operational framework for medicinal and adult-use cannabis operators who want to add cannabis consumption spaces to their dispensary.
In the final public meeting of the year, the New Jersey Cannabis Regulatory Commission (NJ-CRC) voted to approve the reduction of registration and renewal fees for medicinal cannabis patients and their caregivers and to approve the schedule for the 2024 public meetings.
The New Jersey Cannabis Regulatory Commission (NJ-CRC) is seeking public comment on rules to expand the types of ingestible cannabis products. The proposed regulations were developed through a comprehensive process involving input from experts, stakeholders, and the public. During the comment period, which begins on October 16, 2023, and extends until December 15, 2023, the NJ-CRC invites the public, industry stakeholders, and interested parties to submit their feedback on the proposed rules.
Today’s announcement marks an important step forward for the market. Because of the NJEDA’s efforts, that access to capital challenge is a little less daunting to their grant awardees.
New Jersey Cannabis Regulatory Commission to open applications for wholesale, distribution, and delivery cannabis business on September 27 at 9 a.m.
Pre-application Webinar for wholesale, distribution, and delivery cannabis business- September, 14, 2023
First AU only dispensaries open Earth and Ivy and Nova Farms
NJ-CRC February 8, 2023 public meeting actions
NJ-CRC is inviting public input on new rules for cannabis consumption areas
Recreational cannabis sales more than $100 million in 2022 Q3
NJ-CRC approves proposed rules for consumption areas
NJ-CRC approves first annual licenses
NJ-CRC and the NJ Department of State announce free technical assistance program for cannabis entrepreneurs
NJ-CRC public meetings to be held in-person
NJ-CRC public meetings to be held in-person
“WIRE” document affirms existing employer rights and employee protections
Sales figures and tax revenue numbers on recreational and medicinal cannabis
New personal-use rules proposed for readoption and public comment
State sales tax eliminated for medicinal cannabis and products
NJ-CRC approves permanent expanded rules
Executive director Jeff Brown's and ODI director Wesley McWhite's opening remarks for the NJ-CRC's testimony before the Senate Judiciary Committee Testimony on Thursday, May 12, 2022.
Report on customers and sales for first day of recreational cannabis sales
The first day of adult-use cannabis sales goes smoothly
Starting Thursday, April 21 New Jersey residents and visitors 21 years and older will be able to purchase recreational cannabis and cannabis products at 13 dispensaries across the state.
NJ-CRC to give ATCs approval to begin recreational sales on April 21
NJ-CRC approved applications from seven Alternative Treatment Centers
New meeting added to NJ-CRC schedule
The NJ-CRC approved the first 68 conditional recreational business license applications
First day of dispensary applications
Three virtual meetings to be held in March
For the fourth year in a row the NJ Poison Control Center has seen an increase in calls concerning children who accidentally consumed cannabis (marijuana, THC) edibles. Last year (2021), the NJ Poison Control Center assisted in the medical treatment of more than 150 children who were accidentally exposed to cannabis edibles — nearly 100 children 5-years-old and younger; more than 55 children between the ages of 6 and 12.
Por cuatro años consecutivos, el Centro de Control de Envenenamiento de Nueva Jersey ha visto un aumento en las llamadas relacionadas con niños que consumieron accidentalmente comestibles de cannabis (marihuana, THC). El año pasado (2021), el Centro de Control de Envenenamiento de NJ ayudó en el tratamiento médico de más de 150 niños, casi 100 niños de 5 años o menos; más de 55 niños entre las edades de 6 y 12 años que estuvieron expuestos accidentalmente a productos de cannabis.
Hundreds of cannabis entrepreneurs indicate plans to apply for recreational cannabis licenses
Awards and denial decisions made on 14 cannabis cultivation and vertically integrated companies
New Jersey’s Cannabis Regulatory Commission will host an informational webinar on Wednesday, October 13, at 7 p.m. ...
Rules marked by low application fees, priority considerations for minority groups and economically-disadvantaged entrepreneurs
Governor Murphy today announced the appointment of Charles Barker to the Cannabis Regulatory Commission (CRC), completing the five-member commission after previous rounds of appointments in November and February. Mr. Barker will fill the seat previously announced for William Wallace, who will transition to the senior staff role of Director of Labor Relations for the Commission.
Governor Murphy today announced three additional appointments to the Cannabis Regulatory Commission (CRC), completing the five-member commission after previously announcing the appointments of Commission Chair Dianna Houenou and Krista Nash. The Governor will appoint Maria Del Cid and William Wallace to the CRC. The Governor will also appoint Sam Delgado as a member of the Commission, upon the recommendation of Assembly Speaker Craig Coughlin.
Governor Phil Murphy today signed historic adult-use cannabis reform bills into law, legalizing and regulating cannabis use and possession for adults 21 years and older (A21 – “The New Jersey Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act”) and decriminalizing marijuana and hashish possession (A1897). The Governor also signed S3454, clarifying marijuana and cannabis use and possession penalties for individuals younger than 21 years old.
Governor Murphy today announced his appointments of Dianna Houenou as Chair of the Cannabis Regulatory Commission, and Jeff Brown will serve as Executive Director of the Commission. The Governor will also appoint Krista Nash as a member of the Commission, upon the recommendation of Senate President Steve Sweeney.
Governor Phil Murphy today signed the Jake Honig Compassionate Use Medical Cannabis Act to dramatically reform New Jersey’s Medicinal Marijuana Program (MMP) and expand patient access to medical marijuana.
Official Site of The State of New Jersey